These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

130 related items for PubMed ID: 2979266

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Anti-inflammatory activity of a non-steroidal anti-inflammatory agent, oxaprozin, in experimental models].
    Higuchi S, Osada Y, Shioiri Y, Nakaike S, Muramatsu M, Tanaka M, Arai I, Amanuma F, Otomo S, Aihara H.
    Nihon Yakurigaku Zasshi; 1984 May; 83(5):383-94. PubMed ID: 6432656
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [The inhibitory effect of oxaprozin, a new non-steroidal anti-inflammatory drug, on platelet aggregation].
    Goto J, Muramatsu M, Hosoda K, Otomo S, Aihara H.
    Nihon Yakurigaku Zasshi; 1984 May; 83(5):395-400. PubMed ID: 6432657
    [Abstract] [Full Text] [Related]

  • 8. Comparative effects of some non-steroidal anti-inflammatory drugs on the ultrastructural integrity and prostaglandin levels in the rat gastric mucosa: relationship to drug uptake.
    Rainsford KD, Fox SA, Osborne DJ.
    Scand J Gastroenterol Suppl; 1984 May; 101():55-68. PubMed ID: 6443622
    [Abstract] [Full Text] [Related]

  • 9. Design, synthesis, and in-vivo evaluation of 4,5-diaryloxazole as novel nonsteroidal anti-inflammatory drug.
    Zhou XP, Zhang MX, Sun W, Yang XH, Wang GS, Sui DY, Yu XF, Qu SC.
    Biol Pharm Bull; 2009 Dec; 32(12):1986-90. PubMed ID: 19952416
    [Abstract] [Full Text] [Related]

  • 10. Mechanisms of gastrointestinal toxicity of non-steroidal anti-inflammatory drugs.
    Rainsford KD.
    Scand J Gastroenterol Suppl; 1989 Dec; 163():9-16. PubMed ID: 2683030
    [Abstract] [Full Text] [Related]

  • 11. Clinical pharmacokinetics of oxaprozin.
    Davies NM.
    Clin Pharmacokinet; 1998 Dec; 35(6):425-36. PubMed ID: 9884815
    [Abstract] [Full Text] [Related]

  • 12. Oxaprozin-Loaded Lipid Nanoparticles towards Overcoming NSAIDs Side-Effects.
    Lopes-de-Araújo J, Neves AR, Gouveia VM, Moura CC, Nunes C, Reis S.
    Pharm Res; 2016 Feb; 33(2):301-14. PubMed ID: 26350105
    [Abstract] [Full Text] [Related]

  • 13. [The analgesic and antipyretic effects of a non-steroidal anti-inflammatory drug, oxaprozin, in experimental animals].
    Amanuma F, Okuyama S, Orikasa S, Hashimoto S, Yamada C, Sakagawa T, Tsutsui Y, Tarumoto Y, Aihara H, Kameyama T.
    Nihon Yakurigaku Zasshi; 1984 Apr; 83(4):345-54. PubMed ID: 6611288
    [Abstract] [Full Text] [Related]

  • 14. Irritation of gastrointestinal mucosa by new glycosyl derivative of diclofenac in comparison with diclofenac in rats.
    Borowiecka J, Pakulska W, Graczyk J, Wagrowska-Danilewicz M.
    Acta Pol Pharm; 2000 Nov; 57 Suppl():99-102. PubMed ID: 11293281
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Inverse nonlinear pharmacokinetics of total and protein unbound drug (oxaprozin): clinical and pharmacokinetic implications.
    Karim A.
    J Clin Pharmacol; 1996 Nov; 36(11):985-97. PubMed ID: 8973987
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Gastroscopic evaluation of the effect of aspirin and oxaprozin on the gastric mucosa.
    Lanza FL, Hubsher JA, Walker BR.
    J Clin Pharmacol; 1981 Apr; 21(4):157-61. PubMed ID: 7240437
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.